Quality Investor

Kadant Inc.

Rank #277Value

KAI · NYSE · Industrials

Kadant Inc. (KAI) — Rank #277 by gross profitability (GP/assets 0.25) · ROE 10.0% · Piotroski F-Score 5 / 9.

As-of 2026-09-15 · CIK 0000886346 · all metrics point-in-time as of the filing date.

About

Kadant Inc. supplies technologies and engineered systems worldwide.

Show more

The company operates through three segments: Flow Control, Industrial Processing, and Material Handling. The Flow Control segment develops, manufactures, and markets fluid-handling systems, equipment, and integrated technologies, such as rotary joints, syphons, Turbulator bars, expansion joints, and engineered steam and condensate systems, as well as doctor systems and holders, doctor blades, cleaning showers and fabric-conditioning systems, forming systems and wear surfaces, and water-filtration systems. The Industrial Processing segment provides ring and rotary debarkers, stranders, chippers, engineered knife systems, and industrial automation and control products. This segment also offers recycling and approach flow systems, virgin pulping process equipment, boiler cleaning technologies, and single and double-screw presses. The Material Handling segment provides vibratory and conveying equipment; individual components and equipment for baling recyclable and waste materials; and fiber-based products. It sells its products and services through direct sales, independent sales agents, and distributors. The company was formerly known as Thermo Fibertek, Inc. and changed its name to Kadant Inc. in July 2001. Kadant Inc.

was incorporated in 1991 and is headquartered in Westford, Massachusetts.

Industry
Specialty Industrial Machinery
Sector
Industrials
State
DE
Filer Category
Large accelerated filer
Fiscal Year End
January 2
Website
kadant.com

Price History

KAI+26.8% · +4.9% CAGRSPY+80.5% · +12.5% CAGR

Company Snapshot

P/E and dividend yield are the primary valuation lenses for mature businesses.

Market Cap

$3.09B

P/E (annual)

30.2

P/S (annual)

2.9

P/B

3.0

P/OCF (annual)

18.0

Shareholder Yield

0.3%

Employees

4,000

Industry

Specialty Industrial Machinery

Exchange

NYSE

Signal Flags

1 green4 red
Sequential beat (rev + EPS)Both revenue and EPS exceeded prior quarter — 2-quarter streak
Revenue declining YoYRevenue contracted year over year
Operating margin decliningOperating margin lower than prior year
Balance sheet deterioratingNet cash collapsed with receivables or inventory outpacing revenue
Valuation convergenceEPS declining, shares diluting, and revenue growth decelerating simultaneously

Quality Profile

Profitability

1/1 pass
GP / assets
0.25
Return on equity
10.0%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
0.83
Current ratio
2.59×
Net cash
-$241.36M

Cash Flow

3/3 pass
Positive FCF
PASS
Cash-backed earnings
PASS
Accruals healthy
PASS
SBC / revenue
1.1%

Growth

1/2 pass
Revenue growth
-0.1%
Piotroski F-Score
5 / 9
Share dilution
0.2%

Terry Smith quality gate

Passes 1/5 Terry Smith thresholds

1 of 5 threshold not computable from filed data.

What Growth Is Priced In

Implied revenue growth (10Y)

7.7%

incredible deal

The annual FCF growth rate today's price requires over a 10-year horizon (discount rate 10%, terminal growth 2.5%).

Dilution drag: 0.2% — per-share value needs a total required return of 7.9% once share-count change is priced in.

vs. own 6-year median revenue growth: 7.9%

within its own history

Cost-of-equity sensitivity (implied growth at different discount rates)

r = 8%

3.4%

r = 10% (base)

7.7%

r = 12%

11.4%

Net debt / market cap: 7.8%

Base FCF: $154.3M3Y mean FCF: $140.7M

Valuation History

Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.

P / E

Price / diluted EPS

39.8xExpensive
16.7xmed 31.4x39.9x

P / S

Price / revenue per share

3.9xExpensive
1.5xmed 2.8x4.2x

P / B

Price / book value per share

4.1xExpensive
2.5xmed 3.9x5.3x

P / GP

Price / gross profit per share

8.5xExpensive
3.6xmed 6.5x9.6x

P / FCF

Price / free cash flow per share

26.3xFair
12.3xmed 22.9x33.7x

Dividend yield and payout ratio are the primary reads at this stage (trailing P/E — see valuation above).

Profitability

Gross profitability (GP / assets)

0.25

Primary signal (Novy-Marx).

54th pctl of 36 SIC 35 peers

Return on equity

10.0%

Gross margin

45.2%

69th pctl of 36 SIC 35 peers

Revenue growth (YoY)

-0.1%

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2022202320242026
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

5.2%

Revenue CAGR (5Y)

10.6%

Earnings CAGR (3Y)

-5.5%

FCF CAGR (3Y)

27.5%

Anti-fragile safety

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

0.83

49th pctl of 36 SIC 35 peers (best = lowest)

Current ratio

2.59×

77th pctl of 36 SIC 35 peers

Quick ratio

1.35×

Net cash

-$241.36M

Cash & equivalents minus total debt.

Cash-flow health

Free cash flow

$154.28M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF / net income

0.51

Cash-backing of earnings.

FCF/NI divergence

Unfavorable divergence (yellow flag).

PASS

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

1.1%

Stock-based comp intensity.

Dividend safety

Composite score

4.2 / 5

Strong
Payout ratio
15.5%5/5 Strong
FCF coverage
9.78×5/5 Strong
Dividend growth streak
10 yr5/5 Strong
Balance-sheet health
D/E 0.83 · IC N/A2/5 Fair

Piotroski F-Score

F-Score

5 / 9

Fundamental-strength score (0-9).

Lifecycle Phase History

20212026
Value
Op. Leverage
Capital Return